SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001529930-11-000001
Filing Date
2011-09-20
Accepted
2011-09-20 16:13:21
Documents
2
Period of Report
2011-09-16

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 1531
2 POA poahill.txt EX-24 3463
  Complete submission text file 0001529930-11-000001.txt   6403
Mailing Address 929 NORTH FRONT STREET WILMINGTON NC 28401
Business Address 929 NORTH FRONT STREET WILMINGTON NC 28401 9102510081
PHARMACEUTICAL PRODUCT DEVELOPMENT INC (Issuer) CIK: 0001003124 (see all company filings)

IRS No.: 561640186 | State of Incorp.: NC | Fiscal Year End: 1231
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address C/O PHARMACEUTICAL PRODUCT DEVELOPMENT 929 NORTH FRONT STREET WILMINGTON NC 28401
Business Address
Hill Raymond H (Reporting) CIK: 0001529930 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-27570 | Film No.: 111099576